AmoyDx

AmoyDx is a China-based precision oncology diagnostics company focused on molecular testing, companion diagnostics, and in vitro diagnostic products for cancer care. The company develops, manufactures, and commercializes PCR, NGS, FISH, IHC, and nucleic-acid extraction products, with a portfolio spanning lung cancer, breast cancer, ovarian cancer, colorectal cancer, melanoma, and hematologic malignancies. AmoyDx is particularly known for companion diagnostic development with pharmaceutical partners and for its proprietary technology platforms including ADx-ARMS, Super-ARMS, ddCapture, and ADx-HANDLE. Its products are marketed in China and internationally, with approvals and commercial presence in markets including Japan, South Korea, and Europe. The business is primarily a commercial diagnostics company rather than a therapeutics developer.